Cargando…
MAFLD enhances clinical practice for liver disease in the Asia-Pacific region
Fatty liver is now a major cause of liver disease in the Asia-Pacific region. Liver diseases in this region have distinctive characteristics. First, fatty liver is frequently observed in lean/normal-weight individuals. However, there is no standard definition of this unique phenotype. Second, fatty...
Autores principales: | Kawaguchi, Takumi, Tsutsumi, Tsubasa, Nakano, Dan, Eslam, Mohammed, George, Jacob, Torimura, Takuji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Association for the Study of the Liver
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013618/ https://www.ncbi.nlm.nih.gov/pubmed/34753279 http://dx.doi.org/10.3350/cmh.2021.0310 |
Ejemplares similares
-
Non-Obese MAFLD Is Associated with Colorectal Adenoma in Health Check Examinees: A Multicenter Retrospective Study
por: Fukunaga, Shuhei, et al.
Publicado: (2021) -
The Inter-Organ Crosstalk Reveals an Inevitable Link between MAFLD and Extrahepatic Diseases
por: Tsutsumi, Tsubasa, et al.
Publicado: (2023) -
MAFLD associated with COPD via systemic inflammation independent of aging and smoking in men
por: Tsutsumi, Tsubasa, et al.
Publicado: (2022) -
Effects of SGLT2 inhibitor on tumor‐releasing chemokines/cytokines in Hep3B and Huh7 cells
por: Nakano, Dan, et al.
Publicado: (2022) -
Effects of interleukin-17 inhibitors on hepatic fibrosis index in patients with psoriasis and metabolic dysfunction-associated fatty liver disease: Directed acyclic graphs
por: Takamura, Saori, et al.
Publicado: (2022)